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Introduction: There is increasing evidence that deep sedation is detrimental to critically ill patients. The aim of this
study was to examine effects of deep sedation during the early period after ICU admission on short- and long-term
survival.
Methods: In this observational, matched-pair analysis, patients receiving mechanical ventilation that were admitted
to ICUs of a tertiary university hospital in six consecutive years were grouped as either lightly or deeply sedated
within the first 48 hours after ICU admission. The Richmond Agitation-Sedation Score (RASS) was used to assess
sedation depth (light sedation: −2 to 0; deep: −3 or below). Multivariate Cox regression was conducted to
investigate the impact of early deep sedation within the first 48 hours of admission on in-hospital and two-year
follow-up survival.
Results: In total, 1,884 patients met inclusion criteria out of which 27.2% (n = 513) were deeply sedated. Deeply
sedated patients had longer ventilation times, increased length of stay and higher rates of mortality. Early deep
sedation was associated with a hazard ratio of 1.661 (95% CI: 1.074 to 2.567; P = 0.022) for in-hospital survival
and 1.866 (95% CI: 1.351 to 2.576; P <0.001) for two-year follow-up survival.
Conclusions: Early deep sedation during the first 48 hours of intensive care treatment was associated with
decreased in-hospital and two-year follow-up survival. Since early deep sedation is a modifiable risk factor, this data
shows an urgent need for prospective clinical trials focusing on light sedation in the early phase of ICU treatment.Introduction
The management of pain, agitation, stress, discomfort
and delirium are important parts of intensive care unit
(ICU) therapy. However, due to technical improvements
over the past years, deep sedation is no longer required
for obtaining tolerance of mechanical ventilation. Several
guidelines [1-5] recommend an awake and cooperative
patient. Sedation requires a distinct indication, and light
levels should be preferred over deep levels of sedation. If
invasive procedures are performed or under special con-
ditions such as increased intracranial pressure, sedation
may be required for a limited period of time with a well-
defined sedation target [1,6-9].
There is increasing evidence that protocols targeting
sedation to a level that keeps the patients awake and* Correspondence: marc.kastrup@charite.de
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unless otherwise stated.cooperative can result in shorter ventilation time, shorter
ICU stay, lower incidence of delirium and decrease of ICU
mortality [10,11]. Despite the availability of these guide-
lines, surveys have shown that a wide variability exists in
the implementation of these recommendations [12-15]. A
meta-analysis of sedation studies in the ICU has demon-
strated that there is substantial incidence of undesired
deep sedation in up to 40% to 60% of all assessments [16].
Prospective trials have shown a negative impact of early
deep sedation on patient outcome including delayed ex-
tubation, prolonged length of stay (LOS) and increased
mortality [17-19]. In order to validate these findings in a
European health care system and to account for ‘real-life’
conditions away from study protocols, this study investi-
gated the impact of early deep sedation within the first 48
hours of intensive care by means of a retrospective design.
As the term of deep sedation is not clearly defined in the
literature, we supplied a statistically robust definition via a
two-step approach.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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This observational analysis was conducted at a university
hospital in Berlin, Germany. After written consent of the
data authorities and the hospital ethics commission
(Ethikkommission der Charité - Universitätsmedizin
Berlin, EA1/126/08), clinical routine data were acquired
from the two electronic patient data management sys-
tems operated at the hospital (COPRA, Sasbachwalden,
Germany and SAP, Walldorf, Germany). Due to its retro-
spective design, the ethics commission waived the need
of informed consent for this study. We extracted data
from all patients admitted to one of four ICUs of our
department between 2007 and 2012. This included two
interdisciplinary surgical ICUs, one cardiac ICU that
primarily treats patients after cardiac surgery, and one
interdisciplinary ICU that is primarily specialised inFigure 1 Consolidated Standards of Reporting Trials (CONSORT) diagram.treating acute respiratory distress syndrome. A neuro-
surgical ICU also belonging to the department was
excluded. The first 48 hours after ICU admission were
defined as the study period.
Patients aged <18 years, LOS in ICU <48 hours, previ-
ous stays on one of the department’s ICUs during the
same hospital admission, external warming/cooling me-
thods, need for cardiac or pulmonary extracorporeal assist
devices and no mechanical ventilation at the time of ad-
mission were defined as exclusion criteria (see CONSORT
diagram in Figure 1). Furthermore, patients with less than
three measurements for 48 hours were excluded from our
evaluation to avoid a bias due to an unreliable sedation
screening.
At our institution, a nurse-driven monitoring of at least
one assessment per shift and established key performance
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ium scores have been implemented [20,21]. Daily Rich-
mond Agitation-Sedation Score (RASS) targets are assessed
and documented for all patients by the attending physician.
Based on these objectives, sedation is driven by nurses [1].
As the term of deep sedation is not clearly defined in
the literature, we aimed to provide a statistically robust
definition in this study via a two-step approach. Al-
though there is consensus that a RASS measurement
≤−3 describes a state of deep sedation, it is unclear how
this estimation can be applied to a varying number of
RASS measurements in an individual patient. In the first
step of our preliminary analysis, RASS measurements
during the specified time period were converted to sin-
gle continuous variables by calculating the ratio of RASS
measurements ≤−3 and the total number of RASS mea-
surements. This allowed quantification of patients’ de-
gree of deep sedation. Second, we assessed the optimal
cutoff for dichotomously distinguishing between deeply
and not deeply sedated patients in order to attribute
them to two different groups. Therefore, we conducted
receiver operating characteristic (ROC) analyses to in-
vestigate sensitivity and specificity of the previously cal-
culated sedation variable in regards to the dichotomous
outcome parameter of in-hospital mortality. The degree
of deep sedation that resulted in the highest sum of sen-
sitivity and specificity qualified as the best cutoff point
(Youden index). In the resulting ROC diagram, this
value corresponded to the maximal vertical distance be-
tween the ROC curve and the diagonal line [22].
Patient age, gender, body mass index, Acute Physiology
and Chronic Health Evaluation II (APACHE II) admis-
sion score, type of ICU admission (that is medical, emer-
gency surgery, elective surgery), use of inotropics and
sedatives during the 48-hour study period were used to
characterise the study population. Mortality, LOS, time
to extubation, incidence of haemodialysis during the first
48 hours as well as pain and delirium, assessed by the
Confusion Assessment Method in the ICU (CAM-ICU)
for the whole ICU stay [23] were chosen as outcome pa-
rameters. Pain was defined as presence of at least three
positive measurements with a numeric rating scale score
higher than 4 or a score more than 5 on the behavioural
pain scale. Information on long-term mortality, defined as
two years after ICU admission, was acquired after clear-
ance from the federal data safety officer by consulting the
registry office in Berlin, Germany. Patients with shorter
observation intervals, that is less than two years between
ICU admission and date of inquiry at the registry office,
were excluded in analyses on long-term mortality.
Statistical analyses
Descriptive analyses and statistical testing were performed
using the R Project for Statistical Computing 3.0.1 [24]with a P value below 0.05 regarded as significant. When
normal distribution was ruled out using the Kolmogorov-
Smirnov test, results are given in median and interquartile
range (IQR), otherwise mean ± standard deviation (SD).
Qualitative observations are characterised by numbers
with per cent. Statistical significance among groups is
univariately analysed by the exact nonparametric Mann-
Whitney U test. Exact chi-square tests are used for quali-
tative data. In order to account for unequal group size and
to adjust for significantly different factors among groups
that might have affected outcome, deeply sedated patients
were matched to control using APACHE II admission
score and type of admission as matching criteria prior to
multivariate analyses [25]. Survival was analysed using
Kaplan-Meier estimations and tested by the log-rank test
between groups. Testing multivariately for the impact of
early deep sedation on short- and long-term survival,
Cox-regression adjusted for patient age, gender, body mass
index, APACHE II admission score, type of ICU admis-
sion as well as use of inotropic substances and haemodi-
alysis during study period was applied. Sensitivity analyses
were conducted addressing the concern whether the long
study period (that is six consecutive years) might have had
an influence on investigated variables. Therefore, the pro-
portion of deeply sedated patients and defined outcome
variables were compared over time. Furthermore, an alter-
native regression model that included year of admission as
explanatory variable was developed in order to investigate
its impact on outcome. All tests should be understood as
constituting explorative analysis, as no adjustment for
multiple testing has been made.
Results
All patients with complete electronic patient records
(n = 25,931) were screened for eligibility. After selection
regarding inclusion and exclusion criteria, 1,884 patients
were included in the final analysis (Figure 1). Data regard-
ing long-term mortality was available for 1,457 patients
from which 139 had to be excluded since their observation
period was smaller than the previously defined interval of
two years.
In order to set the optimal cutoff point for dichotom-
ously distinguishing between deeply and lightly sedated
patients, we selected the degree of deep sedation that
maximised the vertical distance between the ROC curve
and diagonal line (highest sum of sensitivity and specifi-
city) [22]. Sensitivity analyses for distinguishing between
deeply and not deeply sedated patients resulted in a cut-
off point of 85%. Hence, patients who had more than
85% of documented RASS scores during the study
period equal or below −3 were attributed to the deeply
sedated group (group DS; n = 513). The remaining
patients were labelled as not deeply sedated (group NDS;
n = 1,371). Consequently, deeply sedated patients had a
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P <0.001) and reached a less sedated state defined as
RASS >−3 at a later point of time (78 h [52;141] vs. 11 h
[5;20]; P <0.001). Table 1 gives the summary of descrip-
tive data for the patient population including used drugs
for sedation.
Patients were matched based on APACHE II admis-
sion score and type of admission. Out of 513 deeply se-
dated patients, 510 patients were able to be matched to
a not deeply sedated counterpart. Significant differences
were observed regarding the following characteristics:
Patients of the deeply sedated group were significantly
younger (64 [50;72] vs. 68 [58;75]; P <0.001), inotropic
drugs were used in higher dosages, and benzodiazepines
were more frequently used.
In both unmatched and matched population, deeply
sedated patients showed an increased mortality (ICU, in-
hospital, and long-term), longer LOS (ICU, in-hospital),
longer time to extubation and more frequently need of
renal replacement therapy during first 48 hours after ICU
admission (Table 2). Measured pain was lower in deeply
sedated patients (8.2% vs. 24.5%, P <0.001 in matched






Age [y] 68 [59;75] 64 [50;73]
Male gender 881 (64.3%) 363 (70.8%)
Body mass index 26.2 [23.6;30.7] 27.1 [23.5;31.0]
APACHE II on ICU admission 20 [16;26] 25 [18;31]
Type of admission:
• Elective surgery 697 (53.2%) 136 (27.6%)
• Emergency surgery 348 (26.5%) 170 (34.5%)
• Medical 266 (20.3%) 187 (37.9%)
Inotropics
• None 267 (20.4%) 29 (5.73%)
• Dopamine ≤5 176 (13.5%) 6 (1.19%)
• Dopamine >5 or E/NE ≤0.1 541 (41.4%) 115 (22.7%)
• Dopamine >15 or E/NE >0.1 324 (24.8%) 356 (70.4%)
Sedatives
• Propofol 1048 (76.4%) 191 (37.2%)
• Midazolam 26 (1.9%) 99 (19.3%)
• Both 129 (9.4%) 211 (41.1%)
• None of above 168 (12.3%) 12 (2.34%)
First RASS −4 [−5;-1] −5 [−5;-4]
Time till first RASS [h] 1 [0;4] 2 [1;4]
Time till first RASS >−3 [h] 11 [5;20] 78 [52;141]
APACHE II, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unitsedated patients was seen in the unmatched popula-
tion, but differences were no longer significant after
matching on APACHE II admission score. Kaplan-Meier
curves for time to extubation, in-hospital and long-term
survival are shown in Figures 2, 3, and 4 (log-rank test of
P <0.001 in all figures for group differences).
In order to account for remaining confounders after
pair matching, we conducted Cox regression for both
short-term (that is in-hospital) and long-term (that is
two-year follow-up), adjusting for APACHE II, age, gen-
der, body mass index, type of ICU admission, inotropics
and sedatives. Deep sedation was associated with an ap-
proximately two-fold risk of dying in both short-term
survival (hazard ratio (HR) = 1.661; 95% confidence
interval (CI) 1.074 to 2.567; P = 0.022) and long-term
survival (HR = 1.866; 95% CI 1.351 to 2.576; P <0.001).
Besides deep sedation, APACHE II admission score
remained significant in both regression models (Table 3).
Results of sensitivity analyses regarding the influence of
the long study period revealed that the number of deeply
sedated patients remained constant and that defined study
end points remained considerably stable over time. During
the last five years of the study, the proportion of deeplymatched (right) patient population
Matched (APACHE II and type of admission)





<0.001 68 [58;75] 64 [50;72] <0.001
0.009 319 (62.5%) 361 (70.8%) 0.006
0.176 26.2 [23.8;30.5] 27.1 [23.5;31.0] 0.270
<0.001 25 [18;30] 25 [18;31] 0.552
<0.001 <0.952
142 (28.5%) 136 (27.6%)
169 (33.9%) 170 (34.5%)
188 (37.7%) 187 (37.9%)
<0.001 <0.001
102 (20.7%) 29 (5.73%)
42 (8.52%) 6 (1.19%)
212 (43.0%) 115 (22.7%)
137 (27.8%) 356 (70.4%)
<0.001 <0.001
372 (72.9%) 189 (37.1%)
15 (2.94%) 99 (19.4%)
62 (12.2%) 210 (41.2%)
61 (12.0%) 12 (2.35%)
<0.001 −4 [−5;-1] −5 [−5;-4] <0.001
0.155 1 [0;4] 2 [1;4] 0.051
<0.001 11 [4;21] 79 [52;141] <0.001
; E, epinephrine; NE, norepinephrine; RASS, Richmond Agitation-Sedation Score.
Table 2 Outcome parameters for unmatched (left) and matched (right) patient population










Mortality (ICU) 67 (4.89%) 137 (26.7%) <0.001 37 (7.25%) 137 (26.9%) <0.001
Mortality (hospital) 131 (9.56%) 175 (34.1%) <0.001 67 (13.1%) 175 (34.3%) <0.001
Mortality (2 years) 307 (32.0%) 222 (61.8%) <0.001 126 (39.9%) 222 (62.0%) <0.001
LOS (ICU) [d] 8 [5;16] 21 [12;38] <0.001 10 [6;23] 21 [12;38] <0.001
LOS (hospital) [d] 18 [12;33] 28 [16;48] <0.001 19 [11;38] 28 [16;48] <0.001
Time to extubation [h] 17 [8;33] 75 [37;156] <0.001 21 [10;41] 76 [37;160] <0.001
Delirium 445 (32.5%) 216 (42.1%) <0.001 213 (41.8%) 216 (42.4%) 0.899
Haemodialysis during first 48 hours 153 (11.2%) 204 (39.8%) <0.001 73 (14.3%) 204 (40.0%) <0.001
NRS ≥5 or BPS ≥6 during first 48 hours 342 (24.9%) 42 (8.2%) <0.001 125 (24.5%) 42 (8.2%) <0.001
ICU, intensive care unit; LOS, length of stay; NRS, numeric rating scale; BPS, behavioural pain scale.
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In-hospital mortality decreased over time (17.8% in 2008
to 10.3% in 2012), however these changes were not sta-
tistically significant (P = 0.057). Long-term mortality de-
creased from 39.9% in 2008 to 34.9% in 2012 (P = 0.008).
LOS in the ICU and time to extubation remained statis-
tically unchanged over time (P = 0.755 and P = 0.982,
respectively), see Table S1 in Additional file 1. When the
year of admission was included in an alternative Cox re-
gression model on short- and long-term survival, HRs for
early deep sedation remained essentially stable (short-term
survival: 1.661, 95% CI 1.074 to 2.567, P = 0.022 to 1.685,
95% CI 1.094 to 2.597, P = 0.018; long-term survival:Figure 2 Kaplan-Meier curves for time to extubation (hours from admissio
not deeply sedated; DS, deeply sedated.1.866, 95% CI 1.351 to 2.576, P <0.001 to 1.846, 95% CI
1.339 to 2.545, P <0.001), see Table S2 in Additional file 1.
Discussion
In this observational, matched-pairs analysis, we demon-
strated that early deep sedation impairs clinical out-
comes as it leads to longer mechanical ventilation and
prolonged LOS. In multivariate analyses, early deep sed-
ation was associated with both decreased in-hospital and
two-year follow-up survival. These findings are consist-
ent with recently published trials in other health care
systems. The Australian New Zealand sedation practice
in intensive care evaluation (ANZ SPICE) study includedn to the ICU until extubation of the patient) in matched cohort. NDS,
Figure 3 Kaplan-Meier curve for in-hospital survival (all causes) in matched cohort. NDS, not deeply sedated; DS, deeply sedated.
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ation predicted delayed extubation and increased in-
hospital and 180-day mortality [26]. Results of this study
were replicated in a prospective longitudinal multicentre
cohort study in Malaysian ICUs including 259 patients
from 11 hospitals [19]. Similar, in a secondary analysis of a
multicentre prospective cohort conducted in 45 Brazilian
ICUs, early deep sedation was associated with adverseFigure 4 Kaplan-Meier curves for the two-year survival in matched cohort.outcomes including mortality [27]. In the latter study, the
Glasgow Coma Scale was used as a surrogate for sedation
depth and yielded an increased risk for in-hospital mortal-
ity in deeply sedated patients.
In comparison to previous studies, our analysis com-
prises several novel aspects: First, we propose a definition
of deep sedation in order to contribute to the compara-
bility of studies. The term of ‘over-sedation’ is not clearlyNDS, not deeply sedated; DS, deeply sedated.
Table 3 Cox regression analysis for in-hospital survival (left) and two-year survival (right)
Cox regression for in-hospital survival Cox regression for two-year follow-up survival
P HR 95% CI P HR 95% CI
Deep sedation during first 48 h on ICU 0.022 1.661 1.074-2.567 <0.001 1.866 1.351-2.576
APACHE II on ICU admission <0.001 1.051 1.030-1.073 <0.001 1.045 1.028-1.062
Age [y] 0.072 1.011 0.999-1.022 0.001 1.016 1.007-1.026
Male gender 0.132 0.764 0.538-1.084 0.024 1.375 1.043-1.812
Body mass index 0.043 0.973 0.947-0.999 0.064 0.978 0.955-1.001
Admission: emergency surgery 0.398 0.408 0.051-3.264 0.960 1.021 0.449-2.321
Admission: medical 0.421 1.355 0.647-2.837 0.950 1.016 0.626-1.647
Inotropics: dopamine ≤=5 0.226 1.538 0.766-3.090 0.970 0.991 0.614-1.600
Inotropics: dopamine >5 or E/NE ≤=0.1 0.102 1.473 0.926-2.344 0.764 0.948 0.670-1.341
Inotropics: dopamine >15 or E/NE >0.1 0.321 1.270 0.792-2.037 0.041 1.441 1.015-2.046
Sedatives: propofol 0.877 0.972 0.675-1.399 0.189 1.224 0.905-1.654
Sedatives: midazolam 0.618 1.272 0.494-3.277 0.497 0.823 0.469-1.444
Sedatives: both 0.265 1.779 0.646-4.902 0.326 1.388 0.722-2.667
Haemodialysis during first 48 h on ICU 0.416 1.502 0.564-3.998 0.600 0.850 0.464-1.560
Regression analysis of factors influencing in-hospital and long-term mortality in matched cohort. Reference category for type of admission: elective surgery, for
inotropics: neither dopamine, epinephrine nor epinephrine, for sedatives: none. HR, hazard ratio; CI, confidence interval; APACHE II, Acute Physiology and Chronic
Health Evaluation; ICU, intensive care unit; E, epinephrine; NE, norepinephrine.
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by Jackson et al. demonstrated a wide variation of its
definition [16]. In our study, we conducted ROC analyses
regarding the proportion of deep sedation (that is RASS
measurements ≤−3 and the total number of RASS
measurements) and in-hospital mortality. This way we
accounted for a varying number of RASS measurements
in a defined study period. The resulting Youden index of
85% presented the best cutoff for distinguishing between
deeply and not deeply sedated patients. In consequence,
the duration of deep sedation seems to be relevant, which
supports the practice of sedative interruptions [9]. Second,
the setting of our study was different from previous ana-
lyses. Our analysis was carried out in a different health
care system by using clinical routine data from a major
German university hospital, including a relatively high
number of patients. This approach was intended to reflect
‘real-life’ conditions from a European tertiary medical
centre in order to validate previous findings. Furthermore,
the retrospective study design allowed inclusion of eligible
patients right after admission to the ICU. Therefore, we
considered the depth of sedation from the very beginning
of treatment whereas prospective studies usually imply a
certain delay due to the screening and inclusion process.
Our institutional goal is to measure RASS scores at
least every 8 hours, but more frequently if necessary.
Assuming that score assessment is intensified during
arousal periods or change of target RASS, one has to as-
sume a nearly stable course of RASS between measure-
ments. The time spent deeply sedated would count ifthe assumption was true. This should be investigated
by prospective trials. In this study, we did not address the
question of compliance with our institution’s standard
operating procedures regarding sedation [28]. However,
previous research had yielded strong adherence to quality
indicators for sedation at our institution [29].
Overall it appears that during the very early ICU
period, patients are sedated deeper than during late phases
of treatment. There are no published data explaining
this comprehensively. One possible explanation could
be haemodynamic instability since the deeply sedated
group received higher amounts of vasopressors and ino-
tropics. Of course, this could also be a consequence of
the deep sedation as cause-effect chains cannot be
proven in retrospective designs. The argument that an
increased severity of illness is the cause for deep sed-
ation could be advanced in this context. Even patients
with acute lung injury, usually particularly at risk for deep
sedation, could be treated with less sedatives and kept
awake without signs of delirium in a monocentric rando-
mised controlled trial performed by Hager and colleagues
[30]. Other studies targeting light sedation that included
patients from the beginning of their ICU stay also in-
cluded patients independent of the severity of disease [17].
Whether the sedative itself has an effect on outcome re-
quires further investigation. A recent study suggested that
patients receiving propofol had a reduced risk of mortality
as well as an increased likelihood of earlier ICU discharge
and earlier discontinuation of mechanical ventilation com-
pared to a treatment with benzodiazepines [31].
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There are several limitations that have to be considered
in the interpretation of our results. First, deep sedation
may have been introduced for medical reasons, thus
limiting generalisability of findings. However, this aspect
was militated as much as possible by excluding patients
that were bound for these indications. A neurosurgical
ICU of our centre was not considered eligible, and we
excluded all patients receiving any form of external
warming or cooling (for example patients in need for
cooling after cardiopulmonary resuscitation). Also, pa-
tients requiring extracorporeal assist devices were not
included in analyses. Further indications for sedation like
haemodynamic instability were considered in regression
analyses. Second, the quality of data that was considered
in this retrospective analysis may have been inferior to
that of prospective trials. On the other hand, we think
that the use of retrospective data contributes to creating
a realistic picture of clinical routine. Such analysis may
be essential to validate findings of prospective trials.
Lastly, inclusion of patients from a six-year time period
might suggest an influence on results due to changes of
sedation practices and ICU treatments. However, stand-
ard operating procedures for sedation were introduced
before the start of the study period. Hence, we were able
to rule out an impact due to potential changes of sedation
practice [20,21]. In sensitivity analyses, the proportion of
deeply sedated patients remained constant over the entire
period. Including patient’s admission year in an alternative
multivariate regression analyses did not significantly affect
the previously calculated hazard ratios.
Conclusions
Early deep sedation in the first 48 hours of intensive care
treatment is associated with increased short- and long-
term mortality. To our best of knowledge, this is the first
European study that confirms previous findings of pro-
spective trials and the first that demonstrates it in clin-
ical routine worldwide. The study has an impact on the
design of further prospective trials comparing sedatives
and gives a clear definition for deep sedation.Key messages
 Early deep sedation is a predictor for short- and
long-term mortality in clinical routine.
 Early deep sedation can be defined as more than
85% of RASS values ≤−3 during the first 48 hours
of ICU treatment.
 Although a sedation protocol had been
implemented in the study centre since 2006,
the incidence of early deep sedation was
approximately 30%.Additional file
Additional file 1: Electronic supplement. Tables S1 and S2, which
contain results of statistical analyses concerning the robustness of the
presented data.
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